+499.5%
MRNA vs STLA
-38.0%
+537.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STLA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.3% | -3.5% | -3.1% |
| 7D | +5.5% | +2.6% | +2.9% | +3.2% |
| 30D | +158.7% | -1.2% | +160.0% | +154.8% |
| 3M | +182.1% | -24.8% | +206.9% | +191.9% |
| 6M | +151.8% | -25.6% | +177.4% | +160.5% |
| YTD | +393.6% | -48.9% | +442.5% | +434.7% |
| 1Y | +499.5% | -38.8% | +538.2% | +464.7% |
| All | +499.5% | -38.0% | +537.5% | +464.7% |
Cumulative growth
Daily Returns
Daily percentage return beside STLA.
Daily Out/Under-Performance
Portfolio return minus STLA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STLA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling